Funding research to find cures
Since our creation, Curing Kids Cancer has given more than $10 Million to fund research that will one day cure pediatric cancers.
BREAKING NEWS: The FDA approved CAR T cell therapy for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL) on August 30, 2017. Curing Kids Cancer has supported CAR T cell research at the Children's Hospital of Philadelphia with Dr. Stephan Grupp. Congratulations to Dr. Grupp on an amazing accomplishment that will bring a better treatment to children battling cancer.
- A revolutionary new treatment that Curing Kids Cancer funds is using genetically modified cells from the child's own immune system to treat the most common type of leukemia, acute lymphoblastic leukemia (ALL). Dr. Stephan Grupp at The Children's Hospital of Philadelphia takes T-cells, a type of immune cell, from the patient and then re-engineers the T-cells using a virus so that the T-cells recognize and kill the leukemia cells.
- Curing Kids Cancer is supporting Dana-Farber Cancer Institute's Dr. Andrew Lane's research into why children with Down syndrome have a 20 times higher risk of developing ALL. Lane has tracked the genetic chain of events that links a chromosomal abnormality in Down syndrome to the development of ALL and he discovered it is the same abnormality that causes children who do not have Down syndrome to develop ALL!
- In 2013, Curing Kids Cancer completed a $1.5 million endowment to establish the Killian Owen Curing Kids Cancer Clinical Research Office. This office has already conducted hundreds of clinical trials at Children’s Healthcare of Atlanta that would not have been possible previously. Curing Kids Cancer has provided almost $2 million to CHOA since 2005.
- Curing Kids Cancer funded the development of Moxy, a targeted therapy for childhood leukemia that has already saved many children’s lives since it became available in 2010. Moxy is the second generation of the drug that was pioneered by Killian Owen.
- Curing Kids Cancer funded a three-year, $525,000 commitment to train pediatric oncologist Dr. Eric Schafer at Texas Children's Cancer Center in the pharmacology of childhood cancer. This training makes Dr. Schafer one of only six doctors in the country trained to understand the ways new drugs can work for children who suffer from cancer. This type of training is a major step toward eliminating traditional chemotherapy and its horrible side effects.
- Another $200,000 was committed to the research of Dr. David Poplack, director of the Texas Children's Cancer Center at Texas Children's Hospital and deputy director of Baylor College of Medicine's Dan L. Duncan Cancer Center. Dr. Poplack is co-editor of "Principles and Practice of Pediatric Oncology," the leading textbook of pediatric oncology.
- In 2014 Curing Kids Cancer gave a donation to Ann & Robert H. Lurie Children's Hospital of Chicago to purchase the patent of Xerecept to treat childhood brain tumors.
Curing Kids Cancer focuses on funding some of the world's most innovative and promising treatments for pediatric cancers.
Research we have funded
Aflac Cancer and Blood Disorders Unit at Children's Healthcare of Atlanta
We witnessed firsthand the great work Aflac Cancer Center does when Killian Owen, our inspiration for Curing Kids Cancer, was treated there. The Aflac Center has been recognized as one of the top children's cancer centers by U.S. News and World Report, and we are happy to say Curing Kids Cancer has completed the endowment of the Killian Owen Curing Kids Cancer Clinical Research Office at Aflac Cancer Center.
Texas Children's Hospital
Curing Kids Cancer in funding progressive pharmacology training at Texas Children’s Hospital for three years. The training will make the physician — Eric Schafer, MD, MHS — only the seventh doctor in the country trained to decipher how drugs can work for pediatric cancer patients. It will revolutionize the way children are treated.
University of Texas Southwestern Children's Medical Center/University of Texas Southwestern Medical Center at Dallas
Curing Kids Cancer is helping fund Dr. James Amatruda’s research with zebra fish at UT Southwestern. Dr. Amatruda’s research has already identified the genetic defect that causes a type of bone cancer in children called Ewing’s Sarcoma. Curing Kids Cancer has provided more than $500,000 in total to support Dr. Amatruda's work.
University of Maryland
Curing Kids Cancer fulfilled the second part of a two-year commitment to fund research by Dr. Chen Xiao at the University of Maryland into new more effective drugs to treat leukemia.
Palmetto Health Children's Hospital
Curing Kids Cancer is helping endow a new pediatric oncologist position at Palmetto Health Children's Hospital. This will allow the Center to provide new drugs to patients treated in the South Carolina Center.
Brenner Children’s Hospital
Curing Kids Cancer has provided a grant for funding treatment and research at Brenner Children’s Hospital.
"Blow the Whistle on Kids Cancer" grants
As a part of Curing Kids Cancer's "Blow the Whistle on Kids Cancer" awareness program with major college football teams - including the University of Alabama, Mississippi State University, Vanderbilt University, the University of South Carolina, Texas A&M and the University of Georgia - the following grants were disbursed:
- $25,000 to the Monroe Carell Jr. Children's Hospital at Vanderbilt
- $25,000 to The Children's Hospital of Alabama and the University of Alabama Hospital
- $25,000 to Batson Children's Hospital at The University of Mississippi Medical Center
Portions of donations made to Children's Healthcare of Atlanta, Palmetto Health Children's Hospital, UT Southwestern and Texas Children's Hospital were given in appreciation for their participation in "Blow the Whistle on Kids Cancer."